What's in Corewell Health East's pipeline?

Corewell Health East has 8 drugs in our index: 6 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Corewell Health East's portfolio?

Top competitors by shared drug class: Adam Fedyk, MD, FACS, Ain Shams Maternity Hospital, Ain Shams University, Aligarh Muslim University, Atlantic Health System.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/corewell-health-east.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Corewell Health East — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Corewell Health East pipeline: 6 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

6 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Ropivacaine with NaCl	Ropivacaine with NaCl	marketed	Local anesthetic	Voltage-gated sodium channels	Anesthesia
Early TAP Block	Early TAP Block	marketed
Late TAP Block	Late TAP Block	marketed			Anesthesia/Pain Management
Midazolam and fentanyl	Midazolam and fentanyl	marketed	Benzodiazepine and opioid combination	GABA-A receptor (midazolam); mu opioid receptor (fentanyl)	Anesthesia/Sedation
Povidone-iodine irrigation	Povidone-iodine irrigation	marketed	Topical antiseptic/disinfectant		Infection prevention / Surgical care
Balanced salt solution	Balanced salt solution	marketed	Ophthalmic irrigating solution		Ophthalmology

Therapeutic area mix

Anesthesia · 1
Anesthesia/Pain Management · 1
Anesthesia/Sedation · 1
Infection prevention / Surgical care · 1
Ophthalmology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Adam Fedyk, MD, FACS · 1 shared drug class
Ain Shams Maternity Hospital · 1 shared drug class
Ain Shams University · 1 shared drug class
Aligarh Muslim University · 1 shared drug class
Atlantic Health System · 1 shared drug class
Aultman Health Foundation · 1 shared drug class
B.P. Koirala Institute of Health Sciences · 1 shared drug class
Abant Izzet Baysal University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Corewell Health East:

Cite this brief

Drug Landscape (2026). Corewell Health East — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/corewell-health-east. Accessed 2026-05-18.